Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative return of over 20% within the next six months [6][18]. Core Views - The company is focusing on expanding its product categories internally while also pursuing external growth through acquisitions. The performance in 2024 is expected to be impacted by fluctuations in the operations of its associate company, Weimeizi, and underperformance from its subsidiary, Shanenkang, leading to impairment provisions for long-term equity investments and goodwill [1][5]. - The company has a significant production capacity for toothbrushes and wet wipes, and it is actively expanding its toothpaste category, with production capacity increasing from 60 million to 120 million units [3]. Financial Performance Summary - In Q1 2025, the company achieved revenue of 320 million yuan, a year-on-year increase of 13.3%, but the net profit attributable to the parent company was 10 million yuan, a decline of 34.5% year-on-year [1]. - For the full year 2024, the company reported revenue of 1.3 billion yuan, up 21.8% year-on-year, but a net loss of 80 million yuan, a significant decline of 183.6% year-on-year [1][10]. - The gross margin for 2024 was 23.9%, an increase of 0.7 percentage points year-on-year, with specific margins for oral care and wet wipes being 22.6% and 23.5%, respectively [2][11]. Product Segment Summary - In 2024, toothbrush revenue was 500 million yuan, an increase of 8.5% year-on-year, with sales volume reaching 420 million units, a rise of 14.7%. The average price per unit decreased by 5.5% to 1.19 yuan [1]. - Wet wipes generated revenue of 390 million yuan, up 15.3% year-on-year, with sales volume of 5.28 billion pieces, an increase of 19.0%, while the average price per unit decreased by 4.0% to 0.07 yuan [1]. Strategic Initiatives - The company is enhancing its support for its subsidiary, Shanenkang, focusing on developing major customer relationships and implementing performance evaluation mechanisms to improve its financial performance [4]. - The company is also prioritizing the development of its own brand products alongside its ODM business, aiming for scale growth in toothpaste, toothbrushes, and orthodontic care products while ensuring reasonable profit margins [3].

Core Viewpoint - The company reported a significant increase in revenue for 2024 but faced a net loss due to underperformance in its subsidiaries and impairment provisions [1][2]. Financial Performance - In 2024, the company achieved a revenue of 1.299 billion yuan, a year-on-year increase of 21.78%, but reported a net loss of 77.3161 million yuan, reversing from profit [1]. - For Q1 2025, the company generated a revenue of 324 million yuan, a year-on-year growth of 13.28%, while the net profit was 12.4105 million yuan, down 34.48% compared to the previous year [1]. Subsidiary Performance - The net profit decline in Q1 2025 was primarily attributed to increased losses from the associate company, Weimei Zi, which is currently in a loss position [2]. - Conversely, the subsidiary, Shan'en Kang, achieved a turnaround to profitability in the same quarter [2]. Product Margins - The gross margin for toothbrushes in Q1 2025 was 25.52%, an increase of 1.79 percentage points compared to 2024, while the gross margin for wet wipes was 23.14%, a decrease of 0.4 percentage points [2]. Brand Development Strategy - The company plans to focus its proprietary brand business on three main categories: toothpaste, toothbrushes, and orthodontic oral care products, aiming for scale development while ensuring reasonable profits [2]. - In Q1 2025, the proprietary brand business generated revenue of 27.74 million yuan, a year-on-year increase of 22%, accounting for 8% of total revenue [2]. Overseas Business - In 2024, the overseas business generated revenue of 784 million yuan, representing approximately 60.35% of total revenue [3]. - The company is in the process of establishing a production base in Vietnam, primarily for wet wipes and toothbrushes, with plans for factory renovation already determined [3].